T 0974/20 (HVT-vectored ND-IBD vaccine/INTERVET) of 23.09.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T097420.20220923
- Date of decision
- 23 September 2022
- Case number
- T 0974/20
- Petition for review of
- -
- Application number
- 15817860.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Improved HVT-vectored ND-IBD vaccine
- Applicant name
- Intervet International B.V.
- Opponent name
- Boehringer Ingelheim Animal Health USA Inc.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Amendment after summons - exceptional circumstances (yes)
Amendments - extension beyond the content of the application as filed (no)
Novelty - (yes)
Inventive step - (yes)
Sufficiency of disclosure - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of claims 1 to 7 of the main request filed by letter dated 21 June 2022, received on 22 June 2022, and a description and drawings to be adapted thereto.